Type1Screen

Type1Screen offers Australian & New Zealand residents screening for the early detection of type 1 diabetes. Type1Screen is proudly supported by JDRF Australia.

This involves a blood test at your nearest pathology centre. Early detection can prevent serious illness & improve long term prognosis. Australian and New Zealand residents, who have a family member living with Type 1 Diabetes (T1D), are encouraged to find out more about Type1Screen. A simple blood test is all it takes to find out if you, or your child, at are increased risk of developing the condition. If you have a family history of T1D, when compared to the rest of the population, your risk of developing the condition is greater. Although there is currently no cure, early detection of T1D before symptoms present helps to prevent serious illness and provides options for intervention and prevention trials that may prevent or delay the onset of T1D.

15/01/2026

Supporting teens with type 1 diabetes really matters 💙

A long-term study followed people diagnosed with very young and checked on their health nearly 30 years later.

The study found the years can be a challenging time for blood glucose management. This period deserves extra understanding and support. Blood glucose levels tended to be higher during adolescence than in childhood or adulthood — something many families already recognise.

Importantly, the results suggest how well teens are supported during these years may influence health later in life, particularly around nerve health ( ). This doesn’t mean are inevitable — many people in the study did not develop serious problems — but it highlights as a time when care teams and families can make a positive difference.

💡 Takeaway: The aren’t about perfection — they’re about support, flexibility, and continuity of care, especially as young people transition to adult services. Investing in good support during adolescence can help set people up for better health in the future.

The article is online at: https://doi.org/10.1016/j.diabres.2025.112447

12/01/2026

A recent study compared Swedish children diagnosed with found to have, or not have, (early markers to ). Of the 2753 children studied, 169 (6.1%) did not have any islet autoantibodies detected at diagnosis.

Key characteristics of children without antibodies at diagnosis:
💁‍♂️Gender: More boys (66%) vs. 56% in the autoantibody-positive group.
📈Glucose management: Higher HbA1c (11.3% vs. 10.8%).
⬇DKA Presentation: Less likely to present with ketoacidosis (9% vs. 15%).
👪Family History: More likely to have a parent with (8% vs. 2%).

What this study suggests:
🚸Disease Heterogeneity: T1D can present differently in a minority of children
🐢Slower Progression: lower DKA rates without antibodies indicates a potentially slower disease course, allowing for longer symptom development before diagnosis.
👩‍👩‍👧‍👧Different Etiology: a family history of may bring about insulin resistance in this subgroup, possibly leading to beta-cell (cells that make insulin) exhaustion.

Read more at https://doi.org/10.2337/dc25-0840

09/01/2026

We’d like to take a moment to thank those and Type1Screen families who have participated in the “QuEST Study” (Qualitative Experiences of Screening and monitoring for Type 1 diabetes).

We’re still seeking a few more who have detected through one of these screening programs and have experienced for these, along with their caregivers.

For more or to register your interest, head to this link: https://adelaideuniwide.qualtrics.com/jfe/form/SV_ai1gunhvweaEHjg

In the meantime, we are proud to share with you the first about the perceptions and experiences of around and for .

What is already known about this subject? Screening and monitoring programmes for early-stage type 1 diabetes are being rolled out internationally. To effectively support and their , healthcare professionals must have a clear and comprehensive understanding of these practices.

What has this study found? Healthcare professionals involved in early-stage or clinical type 1 diabetes care gained knowledge through experience, and . However, they lacked knowledge of monitoring practices, type 1 diabetes , initiation, communication and how to support families psychologically.

What are the implications of this study? Findings emphasise critical education opportunities in early-stage type 1 diabetes care.

Read more online at: https://doi.org/10.1111/dme.70178

Sincere thanks to all those participants!

ENDIA

06/01/2026

🧬 What family history really means for type 1 diabetes risk 🧬

A large international study following children from birth brings some reassuring clarity for families living with .

👨‍👩‍👧‍👦 Type 1 diabetes does run in families—but in specific ways.
• Children are more likely to develop early immune changes linked to if a parent or sibling has the condition.
• Risk is also slightly higher if a grandparent, aunt, or uncle has .
⏳ Type 2 diabetes in the family tells a different story.
• Surprisingly, if a child had early warning signs ( ) and a more distant relative with , progression to type 1 diabetes tended to be slower.

🧠 What didn’t increase risk:
• Other autoimmune diseases in the family (like thyroid disease or )
• Other types of diabetes beyond type 1

💡 Why this matters for families:
• Family history doesn’t mean destiny.
• The path to type 1 diabetes appears to happen in stages, influenced by different genetic and environmental factors.
• This opens doors for earlier monitoring, personalized risk discussions, and potentially future prevention strategies.

🔍 Bottom line:
Knowing which type of diabetes runs in your family helps doctors better understand risk—but it doesn’t mean type 1 diabetes is inevitable. 💙 Knowledge is power—for families, clinicians, and researchers working toward prevention.

Read more at https://rdcu.be/eULep

03/01/2026

🤖Can AI Chatbots Help Families Manage Type 1 Diabetes?

A new study in JMIR Diabetes (2025) looked at how tools like ChatGPT could support living with . Researchers at the Montreal Children’s Hospital tested how well an AI chatbot answered real questions from parents and diabetes educators about caring for children with .

✨ What they found:
✅ ChatGPT gave mostly clear, easy-to-understand answers and encouraged families to stay in touch with their diabetes care team.
✅ It could be useful for quick information, translation, and 24/7 access to support.
⚠️ But some answers missed important child-specific details — like checking for when blood sugars are high or adjusting amounts based on a child’s weight.
💬 The takeaway:
AI chatbots can be a helpful extra support tool, but they should never replace trusted . Healthcare providers and families need to work together to ensure these tools are used safely, accurately, and responsibly.
📖 The article is available online at https://doi.org/10.2196/76986

31/12/2025

Thanks for all your support in 2025.
The Type1Screen Team looks forward to supporting the community in 2026

New year
Same hearts
But filled with new gratitude

29/12/2025

🚀 Big changes are happening in type 1 diabetes care

A review article co-authored by Australia's Prof Tom Kay, has helpfully outlined a wave of new developments that could make life easier for people affected by .

✨ New treatments are on the way.
A medicine called has been shown to be able to delay the progression of . Other treatments being tested may help protect the cells in the body that make insulin ( ).

🔎 Earlier checks are making a difference.
More families are getting simple blood tests that can pick up early signs of ( ). This means fewer scary emergency hospital visits and the chance to start treatment sooner.

🧬 Replacing insulin-making cells is changing fast.
Scientists are finding new ways to grow insulin-producing cells from stem cells. They’re also working on protective “coatings” and gene-editing methods that might one day allow these cells to work in the body without needing strong immune-suppressing medicines.

🤖 Day-to-day management is becoming easier.
Glucose monitors ( ) and insulin pumps are now working together automatically, taking some of the pressure off constant decision-making. New types of act faster, last longer, or respond to changes in blood glucose more effectively.

💙 Why this matters:
Some of these advances are already helping a number of people, and many more are on the way. Step by step, these breakthroughs are bringing new hope for the future of people living with type 1 diabetes.

Read the full review article in at https://doi.org/10.1016/S0140-6736(25)01438-2

26/12/2025

🔬 New research using TEDDY Study data identified genetic markers that could predict which children will develop type 1 diabetes—and how quickly.

Australian scientists studied blood samples from 62 children who showed early markers for . By analysing gene activity in blood samples, they found:

- Children who progressed to diabetes showed distinct immune activation patterns in their genes
- A specific gene called SMARCA4 emerged as a key predictor
- A 20-gene signature could distinguish between those who would progress faster and slower

Why it matters: Most children who develop diabetes-related antibodies don't all progress at the same rate—or at all. These genetic markers could help doctors identify which kids need earlier intervention and personalised monitoring.

The findings could pave the way for earlier, more targeted prevention strategies for children at-risk of rapid progression.

Read more online at https://doi.org/10.3389/fimmu.2025.1703839

💙

23/12/2025

Wishing all our Type1Screen friends and families a relaxing, safe and joyful festive season.

20/12/2025

Introducing today's Type1Screen trooper, Mehdi!

Mehdi is a brave 5 year old who participated in Type1Screen because his 10 year old big brother was recently diagnosed with .

We're pleased to report that big brother is doing well and stoicly says, "...it could be worse". Wow. What a superstar! His diabetes educators are amazing and they have helped the family a lot. His mum reports he is not missing out on anything and still having a blast 💥

Sounds like Mehdi is from a family of troopers!

Thank you so much Mehdi, mum and family for supporting Type1Screen, and raising awareness.

💙

17/12/2025

New evidence shows that transplantation of islet cells (the cells that make ) may offer more than stable glucose levels for people with .

A systematic review of 25 studies (1,373 participants) found that both alone and islet-after-kidney transplantation not only helped reduce severe and improve day-to-day levels — the procedure may also protect long-term vascular health.

🔹 Microvascular benefits: Many studies reported stabilisation or even improvement in eye, kidney, and nerve-related complications.
🔹 Kidney outcomes: Long-term kidney function often remained stable after transplant.
🔹 Macrovascular signs: Although data are limited, some studies showed better markers of cardiovascular health, suggesting possible long-term heart-health benefits.

Overall, the review reinforces that for carefully selected adults with , islet transplantation can support both glucose stability and broader vascular health, with especially strong evidence for microvascular protection.

The article is: Gariani K, Peloso A, Haidar F, Kumar R, Wassmer C-H, Morabito M, Krause N, Compagnon P, Berishvili E and Berney T (2025) Impact of Islet Transplantation on Type 1 Diabetes-Related Complication: A Systematic Review. Transpl. Int. 38:15091. https://doi.org/10.3389/ti.2025.15091

Address

Melbourne, VIC

Telephone

+61393427063

Website

http://www.type1screen.org/

Alerts

Be the first to know and let us send you an email when Type1Screen posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed Clinic in Melbourne?